VELA Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,771
| Closed | -$378K | – | 137 |
|
|
2025
Q1 | $378K | Buy |
27,771
+12,136
| +78% | +$165K | 0.12% | 118 |
|
|
2024
Q4 | $319K | Hold |
15,635
| – | – | 0.09% | 123 |
|
|
2024
Q3 | $455K | Buy |
+15,635
| New | +$455K | 0.14% | 117 |
|
|
2024
Q1 | – | Sell |
-26,145
| Closed | -$561K | – | 146 |
|
|
2023
Q4 | $561K | Buy |
26,145
+6,246
| +31% | +$134K | 0.21% | 113 |
|
|
2023
Q3 | $411K | Sell |
19,899
-773
| -4% | -$15.9K | 0.18% | 117 |
|
|
2023
Q2 | $610K | Hold |
20,672
| – | – | 0.28% | 101 |
|
|
2023
Q1 | $476K | Buy |
20,672
+6,926
| +50% | +$160K | 0.22% | 116 |
|
|
2022
Q4 | $382K | Buy |
13,746
+4,905
| +55% | +$136K | 0.19% | 119 |
|
|
2022
Q3 | $271K | Buy |
+8,841
| New | +$271K | 0.15% | 129 |
|